Research delivers insight into the Malignant Mesothelioma Market poised to expand at 8.4% CAGR by 2025

Global malignant mesothelioma market is estimated to represent close to US$ 160 mn, more than 45% revenue share of the total market in 2017 and more than US$ 300 Mn by the end of the forecast period of 2017-2025, expanding at CAGR of 8.4%.

An introduction to the report

All the information pertaining to the market of this rare form of cancer is provided in our recently published report "Malignant Mesothelioma Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)." Caused due to the exposure to toxic asbestos, the occurrence of this cancer is higher in countries such as Russia and China.

These two countries are pegged to represent the most lucrative markets, owing to the relatively high production of asbestos in these countries. Besides, a high consumption of asbestos in the APAC region is expected to create a sizeable opportunity for key players in this market. Our analysts have observed that the rapid substitution through generics to ease availability and affordability is the key focus area in the global malignant mesothelioma market. We have observed that the application of combination therapies is gaining traction in the market across regions.

Click on the link for sample report: https://www.persistencemarketresearch.com/samples/10628

Documented evidence on the adoption of combination treatments and benefits is being made available to ease patients' journey through the treatment process. According to our analysts, there is a great need in the market to efficiently meet the requirements for the present treatment regimen. The drugs that are currently in use do not show much response rates. The malignant mesothelioma treatment market requires drugs to increase the current survival rate.

Acquisitions and collaborations are the key strategies adopted by players to develop molecules for the better treatment of malignant mesothelioma. Companies are focusing on collaborating with established research centers and other cancer drug manufacturers to develop drugs. Our research indicates that the hospital pharmacies distribution channel segment is expected to witness a significant rise in revenue share over the forecast period, owing to the increasing direct procurement of mesothelioma drugs by governments to ensure availability in hospital pharmacies and oncology centers.

We have used our in-house epidemiology data based model to estimate the global malignant mesothelioma market numbers

Weighted average selling price has been considered to estimate the market size of various drugs mentioned in the scope of the study. Price per country is captured with the local currency. The local currency figures are then converted to USD to offer forecasts in a consistent currency standard. We have also considered the latest annual exchange rate to reflect the impact of the most recent economic conditions. Prices considered in the models are standardized based on the average dosage used per malignant mesothelioma treatment per dosage cycle of six months.

Availability of branded off-patent equivalents has been taken into consideration while calculating prices. We have adopted the bottom-up approach to forecast the malignant mesothelioma market globally. Besides this, forecasting is done using our internal proprietary model that considers different macro-economic factors, industry based demand driving factors impacting the market and the relevant forecast trends apart from disease related factors.

Research Methodology

Our research methodology leverages both primary and secondary research to collect the relevant market data. We have analyzed the global malignant mesothelioma market by considering key player revenue, usage patterns, historic trends, and problems faced by oncologists, the required treatment developments, and most preferred drugs.

Key opinion leaders including experienced healthcare professionals in various healthcare facilities at the country level have been considered for primary research. These estimates have been further validated with drug manufacturers, distributors, and suppliers.

Extensive secondary research has been carried out to understand the epidemiology of malignant mesothelioma, treatment rate, adoption rate, regulatory scenarios, average selling price and the global reimbursement scenario by referring to published scientific literature from various databases such as the WHO, Asbestos.com, PubMed, Springer, and Wiley among many others. We have also analyzed the various companies' annual reports_bk_01_01_2020, investor presentations, SEC filings, reports_bk_01_01_2020 and press releases to fetch substantial information pertaining to the market size, trends, opportunities, drivers, and restraints.

Market Taxonomy

Drug Type

• Pemetrexed
• Cisplatin
• Carboplatin
• Gemcitabine
• Vinorelbine
• Others

Route of Administration

• Oral
• Parenteral

Region

• North America
• Latin America
• Europe
• APAC
• MEA

Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Oncology Centers

Click on the link for customized report: https://www.persistencemarketresearch.com/request-customization/10628

This report covers a thorough analysis of:

• Market segment
• Market dynamics
• Market size
• Supply demand
• Current Trends/Issues/Challenges
• Competition and related companies
• Technology
• Value chain

Regional analysis includes:

• North America (USA, Canada)
• Latin America (Mexico, Brazil)
• Western Europe (Germany, Italy, France, UK, Spain)
• Eastern Europe (Poland, Russia)
• Asia Pacific (China, India, ASEAN, Australia and New Zealand)
• Japan
• Middle East and Africa (GCC countries, South Africa, North Africa)

Report highlights:

• Detailed overview of the top markets
• Changing market dynamics of the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• competitive landscape
• Strategies of major players and products provided
• Potential and niche segments, areas showing promising growth
• A neutral view of market performance
• Essential information for market participants to maintain and strengthen their market footprint

Click on the link to access the full report: https://www.persistencemarketresearch.com/checkout/10628

Related Reports -

Heart Valve Repair and Replacement Market: https://www.persistencemarketresearch.com/market-research/heart-valve-repair-replacement-market.asp
Angiography Catheters Market: https://www.persistencemarketresearch.com/market-research/angiography-catheters-market.asp

Contact us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About us:
Persistence Market Research's Expertise in Life Sciences and Transformational Health Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic.

This release was published on openPR.